Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Protein Identified That Maintains the Undifferentiated Morphology of Embryonic Stem Cells

By LabMedica International staff writers
Posted on 05 Nov 2012
A recent paper identified a protein called Utf1 (undifferentiated embryonic cell transcription factor 1) as being a critical to the molecular processes that maintain the undifferentiated morphology of embryonic stem cells.

Utf1 is expressed mainly in embryonic stem cells, is regulated by Oct-3/4 (octamer-binding transcription factor 3/4), and promotes rapid cell proliferation. More...
Oct-4 also known as POU5F1 (POU domain, class 5, transcription factor 1) is a protein critically involved in the self-renewal of undifferentiated embryonic stem cells. As such, it is frequently used as a marker for undifferentiated cells. Oct-4 expression is closely regulated, as too much or too little will cause differentiation of the cells.

The interaction of the factors that coordinate the bivalent chromatin state of embryonic stems cells so they can undergo rapid self-renewal while retaining pluripotency is only poorly understood. To shed light on these factors investigators at the Carnegie Institution for Science (Baltimore, MD, USA) used a combination of genetic, protein-oriented, and physiological approaches to study mouse embryonic stem cells.

They reported in the October 26, 2012, online edition of the journal Cell that Utf1 took part in three diverse molecular processes. First, it maintained the balance between the activation and deactivation of the genes required to direct the cell toward differentiation. Simultaneously, it inserted a molecular tag for degradation onto certain messenger RNAs. In addition, it inhibited a genetic feedback loop that normally prevents cellular proliferation, allowing this process to go forward with the rapidity that is characteristic of embryonic stem cells.

"We are slowly but surely growing to understand the physiology of embryonic stem cells," said senior author Dr. Yixian Zheng, professor of embryology at the Carnegie Institution for Science. "It is crucial that we continue to carrying out basic research on how these cells function."

Related Links:
Carnegie Institution for Science



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.